Disparities in bladder cancer (Q37962703)

26 August 2017

Disparities in bladder cancer (English)

1 reference

26 August 2017

4

Ted A Skolarus

1 reference

26 August 2017

6

Brent K Hollenbeck

1 reference

26 August 2017

Bruce L Jacobs

1

1 reference

26 August 2017

Jeffrey S Montgomery

series ordinal

2

1 reference

26 August 2017

Yun Zhang

series ordinal

3

1 reference

26 August 2017

Alon Z Weizer

series ordinal

5

1 reference

26 August 2017

27 November 2011

1 reference

26 August 2017

1 reference

26 August 2017

30

1 reference

26 August 2017

1

1 reference

26 August 2017

81-88

1 reference

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Contemporary management of stage T1 transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

A study comparing various noninvasive methods of detecting bladder cancer in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Delays in diagnosis and bladder cancer mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Provider treatment intensity and outcomes for patients with early-stage bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

The relationship between socioeconomic status and health: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Revisiting the Behavioral Model and Access to Medical Care: Does it Matter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Deprivation, stage at diagnosis and cancer survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Social class and cancer patient survival in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Breast cancer. Is ethnicity an independent prognostic factor for survival?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Associations between community income and cancer survival in Ontario, Canada, and the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival: findings from the National Longitudinal Mortality Study, 1979-2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Cancer disparities by race/ethnicity and socioeconomic status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Socio-economic factors in the prognosis of cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

County-level poverty and distant stage cancer in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Cancer survival and social class in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Education and risk of cancer in a large cohort of men and women in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Behaviour partly explains educational differences in cancer incidence in the south-eastern Netherlands: the longitudinal GLOBE study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Educational differentials in mortality: United States, 1979-85.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Health risk behaviors: examining social inequalities in bladder and colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

The effects of adjusting for case mix on mortality and length of stay following radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Prevention of bladder cancer: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Association of insurance with cancer care utilization and outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

The relation between health insurance coverage and clinical outcomes among women with breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Access to care: how much difference does Medicaid make?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Disparities in the utilization of high-volume hospitals for complex surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Volume-based referral for cancer surgery: informing the debate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Marital status, delay in seeking treatment and survival from breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

The anticipated physician shortage: meeting the nation's need for physician services

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Twenty-year trends in regional variations in the U.S. physician workforce.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Treatment of Muscle Invasive Bladder Cancer: Evidence From the National Cancer Database, 2003 to 2007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Health care reform--a historic moment in US social policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Survival disparities among African American women with invasive bladder cancer in Florida

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Racial disparity in bladder cancer: trends in tumor presentation at diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Bladder cancer: worse survival in women from deprived areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Gender differences in stage-adjusted bladder cancer survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Patterns of hematuria referral to urologists: does a gender disparity exist?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

A matter of race: early-versus late-stage cancer diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Annual cancer incidence rates for Hispanics in the United States: surveillance, epidemiology, and end results, 1992-1996.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Gender and geographic influence on the racial disparity in bladder cancer mortality in the US.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Survival experience of black patients and white patients with bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Sex and racial differences in bladder cancer presentation and mortality in the US

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Survival of blacks and whites after a cancer diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Bladder cancer: race differences in extent of disease at diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Race and outcomes: is this the end of the beginning for minority health research?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Differences in breast cancer prognosis among African-American and Caucasian women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Why do providers contribute to disparities and what can be done about it?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Racial disparity in rates of surgery for lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Advancing health disparities research within the health care system: a conceptual framework.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Primary care physicians who treat blacks and whites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Racial and ethnic disparities in the receipt of cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

The effect of race and sex on physicians' recommendations for cardiac catheterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

The Contributions of Health Communication to Eliminating Health Disparities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Race and surgical mortality in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

The regionalization of radical cystectomy to specific medical centers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Trends in hospital volume and operative mortality for high-risk surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Health care for black and poor hospitalized Medicare patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Racial disparities in resource utilization for cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Causes of increased hospital stay after radical cystectomy in a clinical pathway setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Factors Influencing Aggressive Therapy for Bladder Cancer: An Analysis of Data From the SEER Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Black/white differences in bladder cancer patient survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Black/white differences in non-treatment of bladder cancer patients and implications for survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

The influence of patient race and social vulnerability on urologist treatment recommendations in localized prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Race, gender, and partnership in the patient-physician relationship

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

A 2020 vision for healthy people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Progress toward the healthy people 2010 goals and objectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

Moving beyond access: achieving equity in state health care reform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

The health impact of resolving racial disparities: an analysis of US mortality data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.011

10.1016/J.UROLONC.2011.08.011

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference